Logo for BioNTech SE

BioNTech Investor Relations Material

Latest events

Logo for BioNTech SE

Q1 2024

Logo for BioNTech

Q1 2024

6 May, 2024
Logo for BioNTech

Q4 2023

20 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from BioNTech SE

Access all reports
Segment Data
Access more data
Revenue by
Business area
Commercial revenues
Research & development revenues
Expenses by
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Additionaly its clinical development will target the treatment of infectious diseases, including prophylactic vaccine approach that includes mRNA. It is also developing various neoantigen-based immunotherapies in collaboration with Pfizer Inc.; other checkpoint molecules; and next-generation antigen receptor T-cell products. The company was formerly known as BioNtech Therapeutics GmbH. BioNTech SE was founded in 2008 and is headquartered in Mainz, Germany.

Key slides for BioNTech SE

Path to Sustained Lo
Logo for BioNTech SE

Innovation Series Day 2023

BioNTech SE
2023 Financial Year
Logo for BioNTech SE

Q3 2023

BioNTech SE
Access 5 more Key Slides on Quartr
Ticker symbol
🇺🇸 United States